The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Boston Scientific Pty Ltd - SYNERGY SHIELD™ Everolimus-Eluting Platinum Chromium Coronary Stent System - Drug-eluting coronary artery stent, biodegradable-polymer-coated (424111)
ARTG Name
Boston Scientific Pty Ltd - SYNERGY SHIELD™ Everolimus-Eluting Platinum Chromium Coronary Stent System - Drug-eluting coronary artery stent, biodegradable-polymer-coated
Product name
SYNERGY SHIELD™ Everolimus-Eluting Platinum Chromium Coronary Stent System - Drug-eluting coronary artery stent, biodegradable-polymer-coated
ARTG Date
Registration Type
Device
Therapeutic good type
Medical device
Sponsor
Manufacturers
Boston Scientific Corporation
Licence category
INC
Licence status
A
Licence class
Class III
Summary